Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens

Cancer Research

Volumn 60, Issue 2, 2000, Pages 235-237

  Newbold, Retha R ^a   Liehr, Joachim G ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Stehlin Found for Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL; CATECHOL ESTROGEN; DIETHYLSTILBESTROL;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET ORGAN; TISSUE DISTRIBUTION; UTERUS CARCINOMA;

ADENOCARCINOMA; ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; CRICETINAE; ESTRADIOL; ESTROGENS, CATECHOL; ETHINYL ESTRADIOL; FEMALE; MICE; UTERINE NEOPLASMS; UTERUS;

EID: 0034650264     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kirkman, H. Estrogen-induced tumors of the kidney in the Syrian hamster, III. Growth characteristics in the Syrian hamster. Natl. Cancer Inst. Monogr., 1: 1-57, 1959.
2. Liehr, J. G., and Sirbasku, D. A. Estrogen-dependent kidney tumors. In: M. Taub (ed.), Tissue Culture of Epithelial Cells, pp. 205-234. New York: Plenum, 1985.
3. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 266: 203-232, 1996.
4. Liehr, J. G., Fang, W. F., Sirbasku, D. A., and Ulubelen, A. A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem., 24: 353-356, 1986.
5. Li, J. J., and Li, S. A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46: 1858-1863, 1987.
6. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res., 50: 7577-7581, 1990.
7. Miller, R. J. Simultaneous Statistical Inference. New York: McGraw Hill, 1966.
8. Siegel, S. Nonparamelric Statistics for the Behavioral Sciences. New York: McGraw Hill, 1956.
9. Greenwald, P., Caputo, T. A., and Wolfgang, P. E. Endometrial cancer after menopausal use of estrogens. Obstet. Gynecol., 50: 239-243, 1977.
10. Siiteri, P. K., Nisker. J. A., and Hammond, G. L. Hormonal basis of risk factors for breast and endometrial cancer. In: S. lacobelli, R. J. B. King, H. R. Linder, and M. E., Lippman (eds.), Hormones and Cancer, pp. 499-505. New York: Raven, 1980.
11. Paria, B. C., Chakraborty, C., and Dey, S. K. Catechol estrogen formation in mouse uterus and its role in implantation. Mol. Cell. Endocrinol., 69: 25-31, 1990.
12. Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan E. V., Hokanson, J. A., and Zhu, B. T. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 9220-9224, 1995.
13. Liehr, J. G. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ. Health Perspect., 105: 565-569, 1997.
14. Liehr, J. G. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur. J. Cancer Prev., 6: 3-10, 1997.
15. Liehr, J. G., Ulubelen, A. A., and Strobel, H. W. Cytochrome P450-mediated redox cycling of estrogens. J. Biol. Chem., 261: 16865-16870, 1986.
16. 5-mediated redox cycling of estrogen. Arch. Biochem. Biophys., 296: 331-338, 1991.
17. Li, Y., Trush, M. A., and Yager, J. D. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis (Lond.), 15: 1421-1427, 1993.
18. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Godden, J. K, Ramanathan, R., Cerny, R. L., and Rogan, E. G. Molecular origin or cancer: catechol estrogen-3.4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
19. Schneider, J., Huh, M. M., Bradlow, H. L., and Fishman, J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259: 4840-4845, 1984.
20. Vandewalle, B., and Lefebvre, J. Opposite effects of estrogen and catechol estrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol. Cell. Endocrinol., 61: 239-246, 1989.
21. Zhu, B. T., Roy, D., and Liehr, J. G. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology, 132: 577-583, 1993.
22. Yager, J. D., Zurlo, J., and Ni, N. Sex hormones and tumor promotion in liver. Proc. Soc. Exp. Biol. Med., 198: 667-674, 1991.
23. nd Int. Symp., . New York: Springer-Verlag, pp. 211-218. Proceedings of the Second International Symposium, 1996.
24. Henderson, B. E., Ross, R. K., and Pike, M. C. Toward the primary prevention of cancer. Science (Washington DC), 244: 1131-1138, 1991.
25. Hulka, B. S., Liu, E. T., and Lininger, R. A. Steroid hormones and risk of breast cancer. Cancer (Phila.), 74: 1111-1124, 1993.
26. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N. Engl. J. Med., 332: 1589-1593, 1995.
27. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.